You are required to be logged in to access the full website
Click here if you have forgotten your username or password
16 June 2026 - Swedish biotech company AlzeCure Pharma AB (Nasdaq First North Premier Growth Market:ALZCUR) on Tuesday reported positive results from the completed Phase Ib clinical study of ACD856, its lead NeuroRestore drug candidate being develope...
16 June 2026 - Minghui Pharmaceutical, a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, announced on Monday the presentation of complete Phase I/II clinical data for MHB0...
16 June 2026 - Clinical-stage biotechnology company Kalohexis Inc announced on Monday that data supporting dual melanocortin-3 receptor/melanocortin-4 receptor (MC3R/MC4R) activation as a novel mechanism to drive healthier, more durable weight loss h...
16 June 2026 - Hillhurst Biopharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known inhaled therapeutics, announced on Monday that the first subject has been dosed in its Ph...
16 June 2026 - US biopharmaceutical company Antharis Therapeutics Inc and Lonza (SWX:LONN), a contract development and manufacturing organisation (CDMO) based in Switzerland, announced on Monday an exclusive, target-specific licensing agreement to de...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe